Weight Loss Anabolic Steroid Powder Methenolone Enanthate Primobolin
CAS 303-42-4 Methenolone Enanthate
Product name: Methenolone Enanthate
Alias: Primobolan depot
CAS No: 303-42-4
EINECS No: 206-141-6
Appearance: White crystalline powder.
Melting point: 66-70°C
Specific optical rotation: +38°-+42°
What is Methenolone Enanthate?
Methenolone enanthate is an anabolic steroid that has small androgenic action. It has potent action on increase of muscle mass. It is a medicine that do not intensify substantially the muscle mass, that is the reason it may be used for a long period of time. The muscle growth provoked by methenolone enanthate maintains even after stopping usage. It is not recommended for use in females because the acetate does not aromatize into estrogen and does not preserve the water in organism. It has properties of fat burning, however it should rather be used for the indicated above purposes. Methonolone enanthate is a drug that may be obtained without prescription. However, patients are indicated to consult a doctor first and get the appropriate dosage for desired purpose.
Metenolone enanthate (methenolone enanthate) is a dihydrotestosterone (DHT) based anabolic steroid.It is an ester derivative of methenolone sold commonly under the brand names Primobolan (tablet form) or Primobolan Depot (injectable). When it interacts with the aromatase enzyme it does not form any estrogens.It is used by people who are very susceptible to estrogenic side effects, having lower estrogenic properties than nandrolone.
Primobolan Depot is an injectable form of the steroid methenolone,it has long been regarded as one of the safest steroids available. Methenolone enanthate has the same base steroid as methenolone acetate. Primobolan Depot has been modified to allow a slow release of methenolone in the body. Primobolan Depot is a moderately anabolic with an extremely low androgenic profile. The anabolic effects are comparable with Deca Durabolin, although the androgenic side effects are considerable less. Athletes and bodybuilders will take Primobolan Depot to gain lean muscle mass. The gains that you will get on a cycle of Primobolan will be a slow gain in quality muscle. You can expect to keep the gains for a few months after finishing your cycle.
An interesting note that is not seen with many other anabolic steroids is that Primobolan has been used to promote weight gain in underweight premature infants and children. Primobolan Depot proved to this effectively without showing signs of toxicity or undesirable side effects.
Primobolan depot Dosage
Injectable Primobolan (Methenolone Enanthate): Beginner Primobolan users will normally find 400mg per weeky Primobolan doses to be sufficient enough to assist the user in achieving their goals. There is seldom ever any need for beginners to venture above 400mg weekly due to the initial use and allowing the individual to gather a feel for the drug’s effectiveness. Intermediate Primobolan doses will land in the range of 400 - 700mg weekly, often being run closer to the higher end of 700mg weekly. Intermediate users will find Primobolan’s anabolic strength quite weak in comparison to other anabolic steroids, and must be utilized at higher doses in order to see any physique/performance changes exclusive to Primo. Advanced users will often end up utilizing Primobolan doses in the range of 800 - 1,000mg per week or greater. For the purpose of preservation of lean mass during a cutting cycle, Primobolan doses do not need to be run this high but on average, these are the doses required to elicit noticeable lean mass increases from a weak anabolic steroid such as Primobolan. However, when run at the appropriate dose range for such effects, Primobolan can put up a display as one of the most impressive anabolic steroids where lean mass addition is concerned.
Female users will find physique and performance enhancing Primobolan dosages in the range of 50 - 100mg weekly without issues of virilization side effects and symptoms. The injectable format of Primobolan, however, has a lower rate of use among females in comparison to the oral variant due to problems over the control of blood plasma levels of the hormone, and the timing and scheduling of injection administrations to achieve this.